Showing results (661-670 of 5,584) with videos related to

Sort By:
Pageof 559
Nuclear Medicine Communications|June 1, 1992
Bone marrow scintigraphy in lung carcinomas using nanosized colloids: when is it useful and how useful is it?P Bourgeois, J Thimpont, W Feremans, et al.
Nuclear Medicine Communications|February 24, 2001
Regional cerebral blood flow in schizophrenia before and after neuroleptic medicationA Yildiz, M Eryilmaz, F Gungor, et al.
Nuclear Medicine Communications|July 17, 2001
Performance of simultaneous emission-transmission systems for attenuation-corrected SPEct: a method for validation applied to two camera systemsH Almquist, K Norrgren, J Palmer, et al.
Nuclear Medicine Communications|March 22, 2001
Detection of myocardial viability using rest-redistribution thallium-201 imaging in a stress 99Tcm-tetrofosmin/rest thallium-201 dual-isotope protocolK Matsuno, Y Kuwabara, S Watanabe, et al.
Nuclear Medicine Communications|March 22, 2001
Detection of residual wall motion after sustained myocardial infarction by gated 99Tcm-tetrofosmin SPECT: a comparison with echocardiographyF F Wahba, C D Bavelaar-Croon, L H Baur, et al.
Nuclear Medicine Communications|March 22, 2001
Prognostic value of 201Tl myocardial scintigraphy after coronary artery bypass graftingL Sarda, L Fuchs, R Lebtahi, et al.
Nuclear Medicine Communications|March 22, 2001
Different chelators and different peptides together influence the in vitro and mouse in vivo properties of 99TcmT Qu, Y Wang, Z Zhu, et al.
Nuclear Medicine Communications|March 22, 2001
Ictal ECD-SPECT differentiates between temporal and extratemporal epilepsy: confirmation by excellent postoperative seizure controlS Weil, S Noachtar, S Arnold, et al.
Nuclear Medicine Communications|March 22, 2001
Correlation of marrow dose estimates based on serial pretreatment radiopharmaceutical imaging and blood data with actual marrow toxicity in anti-CD20 yttrium-90 monoclonal antibody radioimmunotherapy of non-Hodgkin's B-cell lymphomaW D Erwin, S M Spies, M E Kelly, et al.
Nuclear Medicine Communications|June 5, 2001
Increased uptake of 99Tcm-ethyl cysteinate dimer in patients with brain tumoursY Ogawa, R Hashmi, A Aziz, et al.
Pageof 559